Intravoxel incoherent motion MRI for monitoring the therapeutic response of hepatocellular carcinoma to sorafenib treatment in mouse xenograft tumor models

Y Lee, SS Lee, H Cheong, CK Lee, N Kim… - Acta …, 2017 - journals.sagepub.com
Background With the introduction of targeted therapies, there has been a growing need for
non-invasive imaging methods which accurately evaluate therapeutic effects and overcome …

Early response to anti-tumoral treatment in hepatocellular carcinoma–can quantitative contrast-enhanced ultrasound predict outcome?

F Knieling, MJ Waldner, RS Goertz… - Ultraschall in der …, 2013 - thieme-connect.com
Purpose: In order to detect an early response to anti-angiogenic therapy, this study aims at
analyzing specific effects of a sorafenib-based regime on intra-tumoral D-CEUS flow …

[HTML][HTML] Modified transarterial chemoembolization with locoregional administration of sorafenib for treating hepatocellular carcinoma: feasibility, efficacy, and safety in …

M Seidensticker, S Streit, N Nass… - Diagnostic and …, 2016 - ncbi.nlm.nih.gov
PURPOSE We aimed to assess the feasibility, efficacy and safety of a local application of
sorafenib within a conventional transarterial chemoembolization in the VX-2 tumor-bearing …

[HTML][HTML] In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast …

CC Cyran, B Schwarz, PM Paprottka, S Sourbron… - Cancer …, 2013 - ncbi.nlm.nih.gov
Purpose: To investigate dynamic contrast-enhanced magnetic resonance imaging (DCE-
MRI) with macromolecular contrast media (MMCM) to monitor the effects of the multikinase …

Perfusion MRI for monitoring the effect of sorafenib on experimental prostate carcinoma: a validation study

CC Cyran, PM Paprottka, B Schwarz… - American journal of …, 2012 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this study was to investigate with immunohistochemical
validation whether dynamic contrast-enhanced MRI with small-molecule contrast medium is …

Diagnostic value of quantitative perfusion computed tomography technique in the assessment of tumor response to sorafenib in patients with advanced hepatocellular …

D Ippolito, G Querques, A Pecorelli… - Journal of Computer …, 2019 - journals.lww.com
Aim The aim of this study was to assess the role of dynamic contrast-enhanced perfusion
computed tomography (pCT) imaging in the early detection of blood flow changes related to …

Hepatocellular carcinoma treated with sorafenib: arterial tumor perfusion in dynamic contrast-enhanced CT as early imaging biomarkers for survival

Y Nakamura, T Kawaoka, T Higaki, W Fukumoto… - European Journal of …, 2018 - Elsevier
Objectives To investigate whether hepatic perfusion CT yields early imaging biomarkers
predictive of the prognosis of hepatocellular carcinoma (HCC) patients treated with …

Prognostic value of perfusion CT in hepatocellular carcinoma treatment with sorafenib: comparison with mRECIST in longitudinal follow-up

S Kaufmann, WM Thaiss, M Schulze… - Acta …, 2018 - journals.sagepub.com
Background Targeted therapies are of increasing clinical importance and classic radiologic
therapy response-criteria often fail to detect early therapeutic response or failure. For …

Intermediate and advanced hepatocellular carcinoma treated with the antiangiogenic agent sorafenib. Evaluation with unenhanced and contrast-enhanced …

H Moschouris, K Malagari, P Gkoutzios… - Medical …, 2012 - medultrason.ro
Aims: To evaluate the sonographic changes observed in hepatocellular carcinoma (HCC)
post antiangiogenic treatment with sorafenib. Patients and methods: Twenty one …

The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study

M Lewin, L Fartoux, A Vignaud, L Arrivé, Y Menu… - European …, 2011 - Springer
Objective To determine the total Apparent Diffusion Coefficient (ADC), the pure Diffusion
coefficient (D) and the perfusion fraction (f) in advanced hepatocellular carcinoma (HCC) …